SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following?
MEDX 31.58+1.4%Nov 5 12:44 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (1773)7/3/2007 2:33:10 PM
From: LJM  Read Replies (1) of 2240
 
Yesterday's news .. but didn't see it posted anywhere.

Medarex Grants CEO Pien 500,000 Options >MEDX

Jul 2, 2007 18:48:08 (ET)

DOW JONES NEWSWIRES

Medarex Inc. (MEDX) granted its new president and chief executive options for 500,000 shares, the biopharmaceutical company said Monday.

Howard Pien joined the Princeton, N.J., company as its CEO on June 14. He previously was president and CEO of Chiron Corp. until its April 2006 acquisition by Novartis AG (NVS).

The company also granted Pien 225,000 restricted shares, plus another 75,000 shares that will vest depending on whether Medarex shares reach specified price targets.

Medarex shares closed Monday at $14.50 each, up 21 cents.

-Antonie Boessenkool, Dow Jones Newswires; 202-862-7139; antonie.boessenkool@dowjones.com




Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext